Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer.Patrick Michl, Thomas M. Gress, Cláudia Barth et al.|PubMed|2003Cited by 295
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)H Fensterer, Thomas M. Gress, Udo Lindig et al.|Annals of Oncology|2013Cited by 31
Multicenter phase II trial to investigate safety and efficacy of an adjuvant therapy with gemcitabine and cetuximab in patients with R0 or R1 resected pancreatic cancer.H Fensterer, Carmen Schade‐Brittinger, Hans‐Helge Mueller et al.|Journal of Clinical Oncology|2011Cited by 2